John Papastergiou, arguably Canada's most famous pharmacist, business leader, educator, and pharmacy innovator, has joined us in this episode to tell us about the utilization of pharmacogenomics (PGx) in pharmacy practice, the changing role of pharmacists, and a groundbreaking study that showed the effectiveness of PGx for treating depression in a pharmacy setting. 
 

Show Notes: 

How can community pharmacists shape the future of pharmacogenetics?

We’ve had a great conversation with John Papastergiou, a pharmacist and pharmacy owner who has not only implemented pharmacogenetics into his store, but has also conducted a study within his own pharmacy that proves the effectiveness of PGx in pharmacies for treating depression.

0.24 - John’s Background

1:52 - His work as a community pharmacist

5:23 - The changing role of pharmacists

8:47 - How services become commonplace

12:07 - John’s experiences with pharmacogenetics

13:36 - Proving that pharmacies can implement pharmacogenetics

21:46 - When PGx is the key: a patient story

25:16 - Reimbursement: the path to becoming the standard of care

28:35 - The importance of a holistic approach to prescribing

30:08 - What are the next steps?

33:00 - Hear more from John